MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$8,221K
EPS
-$0.43
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
6,811
6,757
6,835*
5,039
General and administrative
3,618
3,845
3,675*
3,006
Total operating expenses
10,429
10,602
10,509
8,045
Loss from operations
-10,429
-10,602
-10,509*
-8,045
Change in fair value of warrant liabilities
-2,483
984
-1,467*
1,811
Loss on issuance of pre-funded warrants
-
-
0*
0
Gain on sale of equipment
-
-
0*
0
Foreign exchange transaction gain
1
13
0*
0
Grant income
0
-
415*
0
Interest income
138
157
226*
199
Interest expense
410
407
203*
426
Total other income (expense), net
2,212
-1,221
1,905*
-2,038
Us federal statutory income tax rate
-
-
-2,077*
-
Domestic state and local taxes, net of federal effect
-
-
0*
-
Foreign tax effects
-
-
5*
-
Research and development credits
-
-
282*
-
Nondeductible stock based compensation
-
-
78*
-
Change in fair value of warrants
-
-
101*
-
Other nontaxable and nondeductible items
-
-
61*
-
Changes in valuation allowance
-
-
2,115*
-
Provision for income taxes
-
-
0*
-
Net loss
-8,217
-11,823
-8,604*
-10,083
Foreign currency translation adjustment
-4
5
-121*
39
Comprehensive loss
-8,221
-11,818
-8,726
-10,044
Basic EPS
-0.43
-0.65
-0.662
-0.6
Diluted EPS
-0.43
-0.65
-0.662
-0.6
Basic Average Shares
19,244,679
18,211,745
13,186,354
16,692,476
Diluted Average Shares
19,244,679
18,211,745
13,186,354
16,692,476
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ELTX Income Statement Sankey Diagram
Sankey diagram visualizing ELTX income statement for the period
Comprehensive loss
-$8,221K
(21.61%↑ Y/Y)
Change in fair value of
warrant liabilities
-$2,483K
(-389.06%↓ Y/Y)
Interest income
$138K
(-17.86%↓ Y/Y)
Foreign exchange
transaction gain
$1K
Net loss
-$8,217K
(22.19%↑ Y/Y)
Foreign currency
translation adjustment
-$4K
(-105.41%↓ Y/Y)
Total other income
(expense), net
$2,212K
(570.64%↑ Y/Y)
Interest expense
$410K
(111.34%↑ Y/Y)
Loss from operations
-$10,429K
(-3.35%↓ Y/Y)
Total operating
expenses
$10,429K
(3.35%↑ Y/Y)
Research and development
$6,811K
(-2.78%↓ Y/Y)
General and
administrative
$3,618K
(17.28%↑ Y/Y)
Buy us a coffee
Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX)